Summary
ChevronTexaco Corporation (now Chevron Corporation) filed an 8-K on November 20, 2002, to report an amendment to its Rights Agreement. The primary impact of this amendment is the acceleration of the expiration date of its Series A Preferred Stock Purchase Rights. Originally set to expire on November 23, 2008, these rights will now expire five years earlier on November 23, 2003. This action means that the company's poison pill defense mechanism, designed to deter hostile takeovers, will be terminated sooner than originally planned. Investors should note that this change could potentially signal a shift in the company's strategic outlook or its perception of takeover risk. The filing also includes a press release related to this amendment, which may provide further context.
Key Highlights
- 1ChevronTexaco Corporation amended its Rights Agreement on November 19, 2002.
- 2The Series A Preferred Stock Purchase Rights will now expire on November 23, 2003.
- 3This represents an acceleration of the expiration date by five years, from the original November 23, 2008.
- 4The amendment effectively shortens the duration of the company's 'poison pill' defense.
- 5A press release was issued in conjunction with the amendment.
- 6The amended Rights Agreement and press release are filed as exhibits.